{"disease":{"id":"nonalcoholic-fatty-liver","name":"nonalcoholic fatty liver"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"pf-05221304","indication_name":"Nonalcoholic fatty liver disease (NAFLD)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-05221304","generic_name":"pf-05221304","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Acetyl-CoA carboxylase (ACC1 and ACC2)","drug_class":"Acetyl-CoA carboxylase inhibitor","quality_score":27,"revenue":null,"mechanism":"Selective inhibitor of acetyl-CoA carboxylase (ACC1/ACC2) that reduces hepatic lipogenesis and promotes fatty acid oxidation."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03847116","title":"Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease","phase":"","overall_status":"COMPLETED","enrollment_count":14014,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT05550688","title":"Weight Gain After Smoking Cessation and NAFLD","phase":"","overall_status":"COMPLETED","enrollment_count":12941,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT03525769","title":"Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07248371","title":"Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":6266,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT04371042","title":"PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07070362","title":"Digital Early Warning System for Acute Lung Injury in Liver Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT06115876","title":"Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Dasman Diabetes Institute","has_results":false},{"nct_id":"NCT03366987","title":"Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT03566173","title":"Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis","phase":"","overall_status":"COMPLETED","enrollment_count":1662,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT06368882","title":"Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT04820556","title":"Gut Microbiota in Chronic Noncommunicable Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":1084,"lead_sponsor_name":"National Medical Research Center for Therapy and Preventive Medicine","has_results":false},{"nct_id":"NCT03726827","title":"A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations","phase":"","overall_status":"COMPLETED","enrollment_count":1006,"lead_sponsor_name":"Fatty liver Foundation","has_results":false},{"nct_id":"NCT05697991","title":"Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"King Saud University","has_results":false},{"nct_id":"NCT04595474","title":"Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":533,"lead_sponsor_name":"Joslin Diabetes Center","has_results":false},{"nct_id":"NCT07149571","title":"To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05625750","title":"Observational Study About Patients Diagnosed With NAFLD","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT05877547","title":"A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03151798","title":"The Liver Health Study for Patients with NAFLD","phase":"NA","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT03248882","title":"Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05583344","title":"Phase 2b Study of GSK4532990 in Adults With NASH","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":284,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04321031","title":"Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04887766","title":"Study on GS300 on NAFLD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Gelesis, Inc.","has_results":false},{"nct_id":"NCT02781584","title":"Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT07237750","title":"iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss","phase":"NA","overall_status":"RECRUITING","enrollment_count":216,"lead_sponsor_name":"Liu Yan","has_results":false},{"nct_id":"NCT05330923","title":"Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04772352","title":"Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT04801849","title":"Vitamin E Dosing Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":true},{"nct_id":"NCT07182136","title":"The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Wei-Hsun Lu","has_results":false},{"nct_id":"NCT03486899","title":"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":197,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT03375580","title":"Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":196,"lead_sponsor_name":"The First Affiliated Hospital of Guangdong Pharmaceutical University","has_results":false},{"nct_id":"NCT04906421","title":"Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Sagimet Biosciences Inc.","has_results":true},{"nct_id":"NCT03059446","title":"Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":167,"lead_sponsor_name":"Tobira Therapeutics, Inc.","has_results":true},{"nct_id":"NCT07146815","title":"PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Ziekenhuis Oost-Limburg","has_results":false},{"nct_id":"NCT03486912","title":"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT06705868","title":"Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Cyprus University of Technology","has_results":false},{"nct_id":"NCT03725631","title":"Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Korea University Guro Hospital","has_results":false},{"nct_id":"NCT04944992","title":"A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06257732","title":"Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines","phase":"NA","overall_status":"UNKNOWN","enrollment_count":144,"lead_sponsor_name":"Yeditepe University","has_results":false},{"nct_id":"NCT01045499","title":"LAGB as a Treatment for Morbid Obesity in Adolescents","phase":"NA","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"Jeffrey L Zitsman, MD","has_results":true},{"nct_id":"NCT02217345","title":"Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT03459079","title":"Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT06482112","title":"Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03763877","title":"A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Poxel SA","has_results":true},{"nct_id":"NCT07007741","title":"Digital Therapy for Fatty Liver Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07168551","title":"Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":111,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05165706","title":"Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance","phase":"NA","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT07363707","title":"A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT04235205","title":"Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Yokohama City University","has_results":false},{"nct_id":"NCT03572465","title":"Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis","phase":"","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false},{"nct_id":"NCT03656744","title":"A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}